GRAMEGNA, ANDREA
GRAMEGNA, ANDREA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Sputum cathepsin G activity predicts exacerbations and hospitalisations in bronchiectasis
2026 M. Nigro, A. Gramegna, E. Johnson, L. Perea, M. Contarini, S. Misuraca, M. Shuttleworth, A. Shoemark, B. Solarat, R. Faner, E. Simonetta, P. Scarano, O. Sibila, F. Blasi, J.D. Chalmers, S. Aliberti
Clinical profile and in-hospital outcomes of patients hospitalised for bronchiectasis exacerbation
2026 F. Bindo, E. Simonetta, A. Gramegna, P. Faverio, P. Scarano, V. Polelli, A. Stainer, F. Amati, M. Nigro, A. Tramontano, S. Mirijaj, P. Curci, M. Mancuso, C. Crimi, F. Luppi, F. Blasi, S. Aliberti
Beta cell function and insulin sensitivity during elexacaftor/tezacaftor/ivacaftor therapy in people with cystic fibrosis
2026 L. Zazzeron, V. Grancini, M. Trombetta, G. Alicandro, M.L. Boselli, I. Cogliati, G. Mantovani, A. Gramegna, F. Blasi, R.C. Bonadonna, E. Orsi, V. Daccò
Nutritional outcomes in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor: A 24-month real-world study
2026 G. Alicandro, L. Zazzeron, V. Visciola, A. Bulfamante, A. Biffi, F. Corti, A. Gramegna, F. Blasi, V. Daccò
Prevalence, type, and clinical implications of CFTR variants in bronchiectasis
2026 A. Gramegna, L. Allavena, G. Alicandro, E. Canella, M. Nigro, C. Premuda, M. Ori, M. Santambrogio, L. Porcaro, D. Prati, L. Valenti, S. Aliberti, F. Blasi
Evaluating current bronchiectasis care in Italy according to the 2025 European respiratory society recommendations
2026 A. De Angelis, V. Comellini, A. Gramegna, S. Battaglia, G. Montemurro, A. Bellofiore, F. Pagnini, E. Privitera, M. Ori, E. Simonetta, M. Nigro, J.D. Chalmers, D. Nobile, F. Blasi, S. Aliberti
Advancing Cystic Fibrosis-Related Diabetes Care With Automated Insulin Delivery Systems
2026 V. Grancini, G. Alicandro, I. Cogliati, A. Oliverio, L. Zazzeron, A. Gaglio, A. Gramegna, V. Daccò, G. Mantovani, F. Blasi, E. Orsi
Biophysical and aerodynamic properties of a peptide targeting the A-kinase anchoring function of PI3Kγ for pulmonary cAMP modulation
2026 A. Della Sala, V. Sala, C.S. Butnarasu, L. Tasca, G. Costabile, M. Mergiotti, A. Gramegna, F. Blasi, S. Aliberti, F. Ungaro, S. Visentin, E. Hirsch, A. Ghigo
Pharmacotherapy options and drug development in bronchiectasis: spotlight on dipeptidyl-peptidase inhibitors
2026 C. Premuda, A. Gramegna, S. Misuraca, F. Piedepalumbo, L. Terranova, M. Santambrogio, M. Contarini, M. Ori, F. Blasi
Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults: an ERS statement
2026 M. Fally, C. Cilloniz, J. Linnell, S. Aliberti, A. Barac, F. Blasi, A. Cumber, P. Dilorenzo, G. Dimopoulos, C. Gainer, W.H. Van Geffen, A. Gramegna, B. Hoehn, E. Polverino, C. Roger, N. Rovina, D. Stolz, G. Waterer, C. Williams, D. Wootton, A.G. Mathioudakis, T.W. Felton
Nonpharmacological interventions for managing infections in chronic respiratory diseases: a comprehensive overview
2026 C. Premuda, M. Santambrogio, S. Misuraca, G. Putti, F. Maraz, A. Sarassi, A. Bulfamante, F. Blasi, A. Gramegna
Bronchiectasis in Italy: an analysis of the EMBARC registry
2026 S. Aliberti, A. Gramegna, E. Simonetta, A. De Angelis, M. Nigro, A. Stainer, F. Amati, S. Battaglia, G. Sotgiu, F. Dente, P. Faverio, O. Sibila, M. Shteinberg, M. Vendrell, K. Dimakou, A. Amorim, E. Polverino, S. Borekci, E. Gerada, J. Pollock, K. Robertson, V. Polelli, M. Santambrogio, M. Retucci, D. Nobile, J.D. Chalmers, F. Blasi
Tackling Neutrophilic Inflammation in Bronchiectasis: From Macrolides to Cathepsin C Inhibitors
2026 A. Gramegna, C. Premuda, G. Putti, F. Piedepalumbo, S. Misuraca, M. Ori, M. Nigro, E. Simonetta, S. Aliberti, F. Blasi
Validation of the Italian version of Bronchiectasis Quality of Life Questionnaire
2026 E. Franceschi, A. De Angelis, A. Gramegna, I. Baiardini, E. Simonetta, M. Nigro, A. Stainer, V. Polelli, F. Bini, F. Braido, F. Blasi, S. Aliberti
Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research
2026 A. Gramegna, G. Putti, G. Alicandro, M.A. Mall, F. Blasi
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter survey
2026 A. Gramegna, C. Magnoni, C. Premuda, G. Alicandro, O. Akkerman, A. Amorim, P. Azevedo, S. Bourke, V. Carnovale, F. Diamantea, L. Fila, F. Frost, R.M. Giron Moreno, C. Pescaru, E. Polverino, A. Felipe Montiel, M. Rachel, G.P. Stoyanova, E. Van Braeckel, S. Volpi, A. Vukić-Dugac, S. Wege, N.J. Simmonds, B.J. Plant, D.G. Downey, S. van Koningsbruggen-Rietschel, P. Burgel, F. Blasi
Pseudomonas aeruginosa induces the generation of pathogenic IFNγ+Th17 cells that promote lung damage and chronic inflammation in cystic fibrosis
2026 I. Dusetti, G. Conte, M. Chiara, S. Puccio, D. Guidone, E. Ricciardelli, J. Cibella, M. Ronzio, D. Dolfini, E. Rossi, P. Landini, M. Ascagni, R. Orlandi, F. Damarco, A. Palleschi, A. Gramegna, F. Blasi, E. Lugli, L.J. Galietta, S. Molin, H.K. Johansen, C. Peano, M. Paroni
Determinants of time to decannulation and predictors of early weaning from tracheostomy: a multicenter, retrospective Italian cohort study
2026 D. Radovanovic, F. Di Marco, M. Mondoni, C. Crimi, A. Gramegna, M. Gatti, J.C. Signorello, F. Raimondi, C. Albrici, G. Morana, F.B.A. Blasi, P. Santus
Opportunities and challenges of adopting a wearable device for sweat chloride monitoring: A qualitative study with experts in cystic fibrosis
2026 C. Bortolotti, S. Canali, A. Gramegna, A. Aliverti, F. Blasi, V. Schiaffonati
Cystic Fibrosis
2025 S. Misuraca, A. Gramegna, F. Blasi